Mutagenesis vol. 13 no. 3 pp. 263-269, 1998
© 1998 UK Environmental Mutagen Society/Oxford University Press
research-article |
Expression of human cytochrome P450 1A2 in Escherichia coli: a system for biotransformation and genotoxicity studies of chemical carcinogens
1Department of Genetics, Faculty of Medical Sciences, New University of Lisbon R. de Junqueira 96, P-1300 Lisbon, Portugal 2Leiden/Amsterdam Center for Drug Research (LACDR), Division of Molecular Toxicology, Free University of Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam,The Netherlands 3FacuIty of Sciences and Technology, New University of Lisbon P-2825 Monte de Caparica, Portugal
In this study we describe the development of strain BMX100, a new Escherichia coli K12 tester strain, derived from MX100, a strain which was constructed for detection of mutagens and for mechanistic studies of chemical carcinogens. We demonstrate here that strain BMX100 can be used for stable expression of human CYP1A2 or human CYP1A2 fused to rat liver NADPH cytochrome P450 reductase. Mutagenicity of precarcinogens known to be bioactivated by CYP1A2, namely 2-aminoanthracene (2-AA), aflatoxin Bl (AFB1) and 2-amino-3-methylimidazo[4,5-f]quinoline (1Q), could be detected. The mutagenic activity of 2-AA using BMX100 expressing CYP1A2 alone and in combination with rat CYP reductase was respectively 10 and 20 times higher than in BMX100 with the standard metabolic activation system, rat liver S9 fraction. Furthermore, the mutagenicity of 2-AA could be nullified by a-naphthoflavone, a known inhibitor of CYP1A2. IQ responded equally in BMX100 expressing the CYP1A2-reductase fusion protein as compared with usage of rat liver S9 fraction. Rat liver S9 fraction was much more potent in generating a mutagenic response to A FBI in BMX100 than in the strain expressing human CYP1A2 aloneZ or CYP1A2 fused to rat reductase. The results described in this study demonstrate that this new E.coli strain can function as a human CYPlA2-competent prokaryotic mutagenicity test system and they seem to characterize BMX100 as a strain of interest for studies to identify individual human CYPs involved in bioactivation and bloinactivation reactions of putative genotoxins.
4To whom correspondence should be addressed. Tel: +351 1 3610290; Fax: +351 1 3622018; Email: jose.rueff{at}gene.unl.mailpac.pt
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. P. Duarte, B. B. Palma, A. Laires, J. S. Oliveira, J. Rueff, and M. Kranendonk Escherichia coli BTC, a human cytochrome P450 competent tester strain with a high sensitivity towards alkylating agents: involvement of alkyltransferases in the repair of DNA damage induced by aromatic amines Mutagenesis, May 1, 2005; 20(3): 199 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Duarte, B. B. Palma, A. A. Gilep, A. Laires, J. S. Oliveira, S. A. Usanov, J. Rueff, and M. Kranendonk The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation Mutagenesis, March 1, 2005; 20(2): 93 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Baker, H. Wayne Taylor, S. P. Lee, S. A. Barker, M. E.P. Goad, and J. C. Means Hepatic Toxicity and Recovery of Fischer 344 Rats Following Exposure to 2-Aminoanthracene by Intraperitoneal Injection Toxicol Pathol, April 1, 2001; 29(3): 328 - 332. [Abstract] [PDF]
|
|
|
|
 |
|
 F. P. Guengerich Metabolism of chemical carcinogens Carcinogenesis, March 1, 2000; 21(3): 345 - 351. [Abstract] [Full Text] [PDF]
|
|